[Kidney transplantation in pediatric age.]

María José Martínez Urrutia1, Roberto Lobato Romera1, Susana Rivas Vila1

  • 1Servicio de Urología Pediátrica. Hospital Infantil La Paz. Madrid. España.

Insights

Kidney transplantation (KT) offers better survival and quality of life for children with end-stage renal disease compared to dialysis. Ongoing research aims to improve long-term graft survival by reducing rejection and immunosuppression side effects.

Area of Science:

  • Pediatric Nephrology
  • Transplant Surgery
  • Immunology

Background:

  • Kidney transplantation (KT) is the optimal treatment for pediatric end-stage renal disease, surpassing dialysis in mortality and quality of life.
  • Broadened inclusion criteria reflect improvements, yet histocompatibility and donor source remain critical for graft longevity.
  • Pediatric KT presents unique challenges, including donor-recipient size discrepancies, growth impact, and adherence issues.

Purpose of the Study:

  • To review the current status and outcomes of kidney transplantation in children.
  • To identify key factors influencing graft survival and patient mortality.
  • To highlight areas for future research, focusing on immunological tolerance and reduced immunosuppression.

Main Methods:

  • Review of recent literature on pediatric kidney transplantation outcomes.
  • Analysis of factors affecting graft and patient survival, including donor type and rejection.
  • Examination of common causes of graft loss and mortality in the first post-transplant years.

Main Results:

  • Five-year graft survival rates are 90% for living donor KT and 70% for cadaveric donor KT.
  • Chronic rejection is the primary cause of graft loss.
  • Mortality within the first post-transplant years is below 6.5%, with infections and cardiovascular issues being leading causes of death.

Conclusions:

  • Pediatric kidney transplantation outcomes have significantly improved, approaching adult results.
  • Reducing immunosuppression and managing chronic rejection are crucial for enhancing long-term graft function.
  • Further research into achieving immunological tolerance is essential for improving pediatric KT success rates.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
76
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
91
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
100
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
19
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
27